Galleon Pharmaceuticals, Inc. Demonstrates Successful Clinical Proof-of-Concept for Lead Product From Sleep Apnea Drug-Discovery Platform
4/11/2013 12:10:44 PM
More...
|
Galleon Pharmaceuticals, Inc. Reports Positive Results from Second Phase I Study of GAL-021 for Treatment of Respiratory Depression
9/20/2012 10:24:35 AM
More...
|
Galleon Pharmaceuticals, Inc. Reports Positive Results from Phase I Study of GAL-021 For Treatment of Respiratory Depression
5/7/2012 9:57:55 AM
More...
|
Galleon Pharmaceuticals, Inc. Reports Positive Results from Phase I Study of GAL-021 for Treatment of Respiratory Depression
5/7/2012 7:42:20 AM
More...
|
Galleon Pharmaceuticals, Inc. Names Lynne Brookes Senior Vice President and Chief Business Officer
12/1/2011 10:18:17 AM
More...
|
Thomas Dietz, Ph.D., Elected Chairman of Galleon Pharmaceuticals, Inc.
10/26/2011 11:52:51 AM
More...
|
Stealthy Galleon Pharmaceuticals, Inc. Sails With $15 Million
12/30/2008 8:44:32 AM
More...
|